BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34663234)

  • 21. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
    Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
    Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people.
    Betés M; Muñoz-Navas MA; Duque JM; Angós R; Macías E; Súbtil JC; Herraiz M; De La Riva S; Delgado-Rodríguez M; Martínez-González MA
    Am J Gastroenterol; 2003 Dec; 98(12):2648-54. PubMed ID: 14687811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tailoring Surveillance Colonoscopy in Patients With Advanced Adenomas.
    Kahi CJ; Myers LJ; Stump TE; Imler TD; Sherer EA; Larson J; Imperiale TF
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):847-854.e1. PubMed ID: 33775897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomographic colonography for colorectal cancer screening: risk factors for the detection of advanced neoplasia.
    Hassan C; Pooler BD; Kim DH; Rinaldi A; Repici A; Pickhardt PJ
    Cancer; 2013 Jul; 119(14):2549-54. PubMed ID: 23754679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals.
    Álvarez C; Andreu M; Castells A; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas Á; Carballo F; Morillas JD; Hernández C; Jover R; Sarasqueta C; Enriquéz-Navascués JM; Hernández V; Estévez P; Macenlle R; Sala T; Balaguer F; Pellisé M; Moreira L; Gil I; Peris A; González-Rubio F; Ferrández A; Poves C; Ponce M; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; Santander C; Díaz Tasende J; Herreros A; Cacho G; Barranco LE; Bessa X;
    Gastrointest Endosc; 2013 Aug; 78(2):333-341.e1. PubMed ID: 23623039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese.
    Cai QC; Yu ED; Xiao Y; Bai WY; Chen X; He LP; Yang YX; Zhou PH; Jiang XL; Xu HM; Fan H; Ge ZZ; Lv NH; Huang ZG; Li YM; Ma SR; Chen J; Li YQ; Xu JM; Xiang P; Yang L; Lin FL; Li ZS
    Am J Epidemiol; 2012 Mar; 175(6):584-93. PubMed ID: 22328705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
    Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
    Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of colorectal advanced neoplasia/adenomas in the long-term follow-up of patients submitted to colonoscopy with polipectomy].
    Rostirolla RA; Pereira-Lima JC; Teixeira CR; Schuch AW; Perazzoli C; Saul C
    Arq Gastroenterol; 2009; 46(3):167-72. PubMed ID: 19918680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Risk Adenomas at Screening Colonoscopy Remain Predictive of Future High-Risk Adenomas Despite an Intervening Negative Colonoscopy.
    Sullivan BA; Redding TS; Hauser ER; Gellad ZF; Qin X; Gupta S; Robertson DJ; Weiss DG; O'Leary MC; Madison AN; Sims KJ; Williams CD; Hong JC; Lieberman D; Provenzale D
    Am J Gastroenterol; 2020 Aug; 115(8):1275-1282. PubMed ID: 32483010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer.
    Regge D; Laudi C; Galatola G; Della Monica P; Bonelli L; Angelelli G; Asnaghi R; Barbaro B; Bartolozzi C; Bielen D; Boni L; Borghi C; Bruzzi P; Cassinis MC; Galia M; Gallo TM; Grasso A; Hassan C; Laghi A; Martina MC; Neri E; Senore C; Simonetti G; Venturini S; Gandini G
    JAMA; 2009 Jun; 301(23):2453-61. PubMed ID: 19531785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.
    Collins MG; Teo E; Cole SR; Chan CY; McDonald SP; Russ GR; Young GP; Bampton PA; Coates PT
    BMJ; 2012 Jul; 345():e4657. PubMed ID: 22833618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.
    Tao S; Hoffmeister M; Brenner H
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):478-85. PubMed ID: 24022090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Designing a Predictive Model for Colorectal Neoplasia Diagnosis Based on Clinical and Laboratory Findings in Colonoscopy Candidate Patients.
    Ghajari H; Sadeghi A; Khodakarim S; Zali M; Nazari SSH
    J Gastrointest Cancer; 2022 Dec; 53(4):880-887. PubMed ID: 34851503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.
    Walshe M; Moran R; Boyle M; Cretu I; Galvin Z; Swan V; Trikovic J; Farrell MP; Foy S; O'Brien L; Leyden J; Mulligan N; Fenlon H; Gallagher DJ; MacMathúna P
    Cancer Epidemiol; 2017 Oct; 50(Pt A):30-38. PubMed ID: 28783501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test.
    Cha JM; Lee JI; Joo KR; Shin HP; Park JJ; Jeun JW; Lim JU
    Digestion; 2012; 86(4):283-7. PubMed ID: 23051697
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.